Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: Cholangiocarcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 9, 2011, Pages 2209-2213

  Kamsa ard, Supot ^a   Wiangnon, Surapon ^a   Suwanrungruang, Krittika ^a   Promthet, Supannee ^a   Khuntikeo, Narong ^a   Kamsa ard, Siriporn ^a   Mahaweerawat, Suwannee ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Cancer registry data; Cholangiocarcinoma; Incidence rate; Khon kaen; Thailand; Time trends

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; FEMALE; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; REGISTER; THAILAND;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; REGISTRIES; THAILAND; YOUNG ADULT;

EID: 84866286069     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Amon1 JJ, Nedsuwan S, Chantra S, et al (2005). Trends in liver cancer, Sa Kaeo Province Thailand. Asian Pac J Cancer Prev, 6, 382-386.
2. Bray F, Parkin DM (2009). Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness. Eur J Cancer, 45, 747-755.
3. Bureau of Policy and Strategy, Ministry of Public Health. [Online] 2009 [cited 2010 Oct 1]. Available from http://bps.ops.moph.go.th/
4. Cancer Unit, Khon Kaen University. Tumor Registry 2009. (2010). Khon Kaen: Faculty of Medicine, Srinagarind Hospital Khon Kaen University.
5. Deerasamee S, Martin N, Sontipong S, et al, editors (1999). Cancer in Thailand Vol. II, 1992-1994. IARC Technical Report No. 34, Lyon: IARC.
6. Elkins DB, Haswell-Elkins MR, Mairiang E, et al (1990). A high frequency of hepatobiliary disease and suspected cholangiocarcinoma associated with heavy Opisthorchis viverrini infection in a small community in northeast Thailand. Trans R Soc Trop Med Hyg, 84, 715-719.
7. Ferlay J, Burkhard C, Whelan S, Parkin DM (2005). Check and conversion programs for cancer registries (IARC/IACR tools for cancer registries). IARC technical report no. 42. Lyon: IARC; 2005.
8. Fritz A, Percy C, Jack A, et al (2000). International Classification of Disease for Oncology, 3rd Edition. ICD-O. Geneva: World Health Organization.
9. International Association of Cancer Registries. Software [on line] 2004 [cited 2004 Dec 7]. Available from: http://www.iacr.com.fr/ International rules for multiple primary cancers (ICD-O Third edition), IACR, Lyon 2004.
10. Jensen OM, Parkin DM, Maclennan R, et al (1991). Cancer registration: principles and methods. IARC scientific publications No.95, Lyon, 159-176.
11. Khuhaprema T, Srivatanakul P, Attasara P, Sriplung H, Wiangnon S, Sumitsawan Y. editors (2010). Cancer in Thailand Vol. V, 2000-2003. Bangkok: Bangkok Medical Publisher; 2010.
12. Khuhaprema T, Srivatanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P. Editors (2007). Cancer in Thailand Vol. IV, 1998-2000. Bangkok: Bangkok Medical Publisher.
13. Kim HJ, Fay MP, Feuer EJ, et al (2000).Permutation tests for Joinpoint regression with applications to cancer rates. Stat Med, 19, 335-351.
14. Mairiang E, Chaiyakuma J, Chamadola N, et al (2006). Ultrasound screening for Opisthorchis viverrini-associated cholangiocarcinomas: Experience in an endemic area. Asian Pacific J Cancer Prev, 7, 431-433
15. Mairiang E, Elkins DB, Mairiang P, et al (1992). Relationship between intensity of Opisthorchis viverrini infection and hepatobiliary disease detected by ultrasonography. J Gastroenterol Hepatol, 7, 17-21.
16. Ministry of Public Health. Public Statistics (2009). Bangkok: Bureau of Policy and Strategy.
17. National Cancer Institute. Joinpoint regression program, version 2.7, September 2003. Available at http://srab.cancer.gov/joinpoint.
18. Parkin DM, Bray F (2009). Evaluation of data quality in the cancer registry: Principles and methods. Part II: Completeness. Eur J Cancer, 45, 756-764.
19. Parkin DM, Ohshima H, Srivatanakul P, Vatanasapt V (1993). Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev, 2, 537-544.
20. Parkin DM, Wabinga H, Nambooze S (2001). Completeness in an African cancer registry. Cancer Causes Control, 12, 147-152.
21. Prime Minister's Office. Population projections for Thailand 2000-2030. Office of the national economic and social development board. October 2007.
22. Qiu D, Hirabayashi Y. Comparison of time trends in liver cancer incidence (1973-1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vol. IV-VIII (2007). Jpn J Clin Oncol, 37, 402-403.
23. Sripa B (2005). Etiology and pathogenesis of cholangiocarcinoma: Introduction to the association with liver fluke Infection. Srinagarind Med J, 20, 122-134
24. Sripa B (2011). Liver flukes and cholangiocarcinoma: Major neglected foodborne trematodes and their related diseases. Tropical Disease Research. Software [online] 2007 [cited 2011 Aug 9]. Available from: http://www.tdr.kku.ac.th/
25. Sriplung H, Sontipong S, Martin N, et al (2003). Cancer in Thailand Vol. III, 1995-1997. Bangkok: Bangkok Medical Publisher; 2003.
26. Srivatanakul P, Parkin DM Jing YZ, et al (1991). The role of infection by Opisthorchis viverrini, hepatitis B virus, and aflatoxin exposure in the etiology of liver cancer in Thailand. A correlation study. Cancer, 68, 2411-2417.
27. Suwanrungruang K, Sriplung H, Attasara P, et al (2011). Quality of case ascertainment in cancer registries: A proposal for a virtual three-source capture-recapture technique. Asian Pac J Cancer Prev, 12, 173-178.
28. Upatham ES, Viyanant V, Brockelman WY, et al (1988). Rate of re-infection by Opisthorchis viverrini in an endemic northeast Thai community after chemotherapy. Int J Parasitol, 18, 643-669.
29. Vatanasapt V, Martin N, Sriplung H, et al (1993). Cancer in Thailand 1988-1991. (IARC Technical Report No. 16), Lyon, IARC.
30. Vatanasapt V, Martin N, Sriplung H, et al (1995). Cancer incidence in Thailand 1988-1991. Cancer Epidemiology, Biomarkers Prev, 4, 475-483.